title: The ageing endocrine system: Fracture risk after initiation of antihypertensive therapy.
authors: Lars
authors: L
authors: Rejnmark
mesh_terms: D000375:Aging / Q000502:physiology*; D000959:Antihypertensive Agents / Q000009:adverse effects*; D004703:Endocrine System / Q000187:drug effects*; D050723:Fractures, Bone / Q000139:chemically induced*; D006801:Humans
chemical_list: D000959:Antihypertensive Agents
references: Osteoporos Int. 2012 Mar;23(3):963-70
references: 21505909
references: Pharmacoepidemiol Drug Saf. 2011 Aug;20(8):879-84
references: 21744415
references: Arch Intern Med. 2012 Dec 10;172(22):1739-44
references: 23165923
references: Arch Osteoporos. 2012;7:237-46
references: 23060309
references: Cochrane Database Syst Rev. 2011 Oct 05;(10):CD005185
references: 21975748
references: J Intern Med. 2006 Oct;260(4):350-62
references: 16961672
references: Am J Med. 1987 Jan 26;82(1B):27-33
references: 3544831
references: Curr Drug Saf. 2008 Sep;3(3):178-84
references: 18690998
references: Calcif Tissue Int. 2009 Feb;84(2):103-11
references: 19067019
references: J Bone Miner Res. 2011 Jul;26(7):1561-7
references: 21312268